Physician profile
Sandra Webb
NPI 1801332903
$7,119.85
in general payments reported to CMS, 2019-2025
29 companies · $2,081 in 2025
The $2,081 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $691 · 2022: $968 · 2023: $1,519 · 2024: $1,860 · 2025: $2,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,425 · Education: $35.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,425.38 |
| Education | $35.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,306.00 | 2021-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $1,095.18 | 2021-2025 | Airsupra, Fasenra, Breztri |
| Insmed, INC. | $969.61 | 2022-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $646.23 | 2021-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| United Therapeutics Corporation | $405.18 | 2022-2025 | Tyvaso, Tyvaso |
| Grifols USA, LLC | $346.20 | 2021-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $283.39 | 2022-2025 | Glassia |
| Regeneron Healthcare Solutions, INC. | $223.63 | 2022-2025 | Dupixent |
| Mylan Specialty L.P. | $208.96 | 2022-2024 | Yupelri |
| Baxter Healthcare | $178.01 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Pulmonx Corporation | $171.18 | 2023-2024 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Janssen Pharmaceuticals, INC | $165.05 | 2021-2022 | |
| Electromed, INC. | $151.88 | 2024-2025 | Smartvest |
| Philips North America LLC | $135.54 | 2023-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Viatris Specialty LLC | $133.17 | 2025 | Yupelri |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $128.99 | 2023-2025 | |
| Genzyme Corporation | $93.55 | 2022-2025 | |
| Olympus America INC. | $85.57 | 2022 | |
| Verona Pharma, INC. | $77.05 | 2025 | Ohtuvayre |
| Janssen Biotech, INC. | $75.71 | 2021-2024 | Stelara |
| Bayer Healthcare Pharmaceuticals INC. | $53.71 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $46.25 | 2022-2023 | Acthar |
| Actelion Pharmaceuticals US, INC. | $33.42 | 2024 | Uptravi, Opsumit |
| Tactile Systems Technology INC | $25.32 | 2025 | Flexitouch Plus, Nimbl |
| Genentech USA, INC. | $17.93 | 2021 | |
| Harmony Biosciences LLC | $16.91 | 2022 | |
| Jazz Pharmaceuticals INC. | $16.90 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.38 | 2023 | Eliquis |
| Foundation Medicine, INC. | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.